Waters Net Common Equity Issued/Repurchased 2010-2024 | WAT
Waters annual/quarterly net common equity issued/repurchased history and growth rate from 2010 to 2024. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
- Waters net common equity issued/repurchased for the quarter ending December 31, 2024 was $0.017B, a 141.56% decline year-over-year.
- Waters net common equity issued/repurchased for the twelve months ending December 31, 2024 was $0.038B, a 117.08% decline year-over-year.
- Waters annual net common equity issued/repurchased for 2024 was $0.017B, a 141.56% decline from 2023.
- Waters annual net common equity issued/repurchased for 2023 was $-0.04B, a 93.06% decline from 2022.
- Waters annual net common equity issued/repurchased for 2022 was $-0.583B, a 1.69% decline from 2021.
| Waters Annual Net Common Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2024 | $17 |
| 2023 | $-40 |
| 2022 | $-583 |
| 2021 | $-593 |
| 2020 | $-130 |
| 2019 | $-2,416 |
| 2018 | $-1,263 |
| 2017 | $-235 |
| 2016 | $-264 |
| 2015 | $-283 |
| 2014 | $-264 |
| 2013 | $-233 |
| 2012 | $-267 |
| 2011 | $-311 |
| 2010 | $-196 |
| 2009 | $-192 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $20.727B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $190.614B | 83.49 |
| Thermo Fisher Scientific (TMO) | United States | $159.404B | 19.28 |
| Alcon (ALC) | Switzerland | $48.032B | 31.93 |
| Edwards Lifesciences (EW) | United States | $44.155B | 28.89 |
| IDEXX Laboratories (IDXX) | United States | $38.206B | 43.91 |
| DexCom (DXCM) | United States | $31.474B | 48.65 |
| IQVIA Holdings (IQV) | United States | $26.853B | 14.86 |
| Mettler-Toledo (MTD) | United States | $22.677B | 26.97 |
| STERIS (STE) | Ireland | $22.038B | 25.20 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.648B | 0.00 |
| Hologic (HOLX) | United States | $11.751B | 12.77 |
| Sysmex ADR (SSMXY) | Japan | $11.664B | 0.00 |
| Penumbra (PEN) | United States | $11.352B | 89.10 |
| Globus Medical (GMED) | United States | $9.697B | 22.45 |
| Masimo (MASI) | United States | $8.800B | 36.93 |
| Teleflex (TFX) | United States | $5.431B | 8.96 |
| Glaukos (GKOS) | United States | $4.963B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.067B | 21.31 |
| TransMedics (TMDX) | United States | $3.119B | 91.30 |
| PROCEPT BioRobotics (PRCT) | United States | $3.010B | 0.00 |
| Veracyte (VCYT) | United States | $2.453B | 44.11 |
| Nihon Kohden (NHNKY) | Japan | $2.160B | 11.81 |
| LivaNova (LIVN) | United Kingdom | $1.978B | 11.97 |
| Elekta AB (EKTAY) | Sweden | $1.956B | 17.59 |
| Alphatec Holdings (ATEC) | United States | $1.751B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.418B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.116B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.026B | 5.49 |
| Artivion (AORT) | United States | $1.015B | 95.08 |
| AxoGen (AXGN) | United States | $0.763B | 0.00 |
| IRadimed (IRMD) | United States | $0.665B | 33.74 |
| Mesa Laboratories (MLAB) | United States | $0.644B | 14.08 |
| SiBone (SIBN) | United States | $0.606B | 0.00 |
| RxSight (RXST) | United States | $0.595B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.561B | 9.03 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.528B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.512B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.506B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.460B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.401B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.388B | 0.00 |
| NeuroPace (NPCE) | United States | $0.378B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.366B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.333B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.330B | 19.63 |
| Semler Scientific (SMLR) | United States | $0.322B | 6.84 |
| Neuronetics (STIM) | United States | $0.296B | 0.00 |
| CVRx (CVRX) | United States | $0.203B | 0.00 |
| 908 Devices (MASS) | United States | $0.193B | 0.00 |
| Inogen (INGN) | United States | $0.187B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.183B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.169B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.151B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.147B | 0.00 |
| Accuray (ARAY) | United States | $0.135B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.132B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.114B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.097B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.067B | 10.18 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.054B | 0.00 |
| Hyperfine (HYPR) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.050B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.036B | 0.00 | |
| Biosig Technologies (BSGM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.34 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |